loxoprofen has been researched along with Itching in 3 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 36-year-old female patient was transferred to Gunma University Hospital, Maebashi, Japan, with progressive pruritus and jaundice that developed after 5-day treatment with 120 mg/d of loxoprofen (maximum recommended dose, 180 mg/d) for menstrual pain." | 3.74 | Prolonged intrahepatic cholestasis after exposure to loxoprofen. ( Ichikawa, T; Kaira, K; Kakizaki, S; Mori, M; Oh-I, S; Sato, H; Sato, K; Takagi, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Katagiri, K | 1 |
| Ichikawa, T | 1 |
| Sato, H | 1 |
| Kaira, K | 1 |
| Oh-I, S | 1 |
| Kakizaki, S | 1 |
| Sato, K | 1 |
| Takagi, H | 1 |
| Mori, M | 1 |
3 other studies available for loxoprofen and Itching
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Aspirin and loxoprofen relieve refractory pruritus in patients with prurigo nodularis.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, No | 2016 |
Prolonged intrahepatic cholestasis after exposure to loxoprofen.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bilirubin; Cholestasis, Intrahepatic; Drugs, Chinese | 2008 |